| 1. |
News in brief… |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1081,
1997,
Page 2-2
&NA;,
Preview
|
PDF (1067KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 2. |
Current controversies in acute paediatric asthma |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1081,
1997,
Page 3-4
Peter Harrigan,
Preview
|
PDF (2183KB)
|
|
摘要:
A lively debate regarding the administration of ipratropium bromide in acute childhood asthma, and the use of inhaled corticosteroids as first-line preventive therapy, took place during the recent International Paediatric Respiratory Congress [Sydney, Australia; March 1997].
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 3. |
News in brief… |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1081,
1997,
Page 4-4
&NA;,
Preview
|
PDF (1092KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 4. |
… and the management of paediatric pneumonia |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1081,
1997,
Page 5-5
&NA;,
Preview
|
PDF (1010KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 5. |
SSRIs in depression - fewer adverse events, fewer costs |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1081,
1997,
Page 6-6
&NA;,
Preview
|
PDF (1049KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 6. |
Propranolol advocated as prophylaxis against variceal bleeding in cirrhosis |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1081,
1997,
Page 7-7
&NA;,
Preview
|
PDF (1108KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 7. |
Muscle-directed gene therapy looks promising |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1081,
1997,
Page 8-8
&NA;,
Preview
|
PDF (1012KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 8. |
News in brief… |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1081,
1997,
Page 9-9
&NA;,
Preview
|
PDF (1035KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 9. |
News in brief… |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1081,
1997,
Page 10-10
&NA;,
Preview
|
PDF (1012KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 10. |
New recombinant thrombolytics pose a threat to alteplase |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1081,
1997,
Page 11-12
Gill Higgins,
Preview
|
PDF (2116KB)
|
|
摘要:
Alteplase is considered to be the gold standard of thrombolytic therapy by many cardiologists. However, the new genetically engineered versions of alterplase may take on this esteemed role in the future, according to reports at the 46th Annual Scientific Sessions of the American College of Cardiology [Anaheim, US; March 1997].
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
首页
